Cerberus Capital Management is weighing a sale of Covis Pharma Holdings Sarl, which could fetch about $800 million, Bloomberg reported. Covis, a specialty pharmaceutical company, has attracted attention from private equity, the story said.
Cerberus Capital Management is weighing a sale of Covis Pharma Holdings Sarl, which could fetch about $800 million, Bloomberg reported. Covis, a specialty pharmaceutical company, has attracted attention from private equity, the story said.
Copyright PEI Media
Not for publication, email or dissemination